Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development.
Takeuchi Y, Ikeda F, Osawa T, Araki Y, Takaguchi K, Morimoto Y, Hashimoto N, Sakaguchi K, Sakata T, Ando M, Makino Y, Matsumura S, Takayama H, Seki H, Nanba S, Moritou Y, Yasunaka T, Ohnishi H, Takaki A, Nouso K, Iwasaki Y, Yamamoto K.
Takeuchi Y, et al. Among authors: matsumura s.
World J Hepatol. 2015 Sep 8;7(19):2220-8. doi: 10.4254/wjh.v7.i19.2220.
World J Hepatol. 2015.
PMID: 26380048
Free PMC article.